These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4- isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs. Jackson A; Brown G; Stephens DN Psychopharmacology (Berl); 1996 Dec; 128(3):320-7. PubMed ID: 8972552 [TBL] [Abstract][Full Text] [Related]
5. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists. Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947 [TBL] [Abstract][Full Text] [Related]
6. Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists. Reeves R; Thiruchelvam M; Cory-Slechta DA Toxicol Sci; 2004 May; 79(1):123-36. PubMed ID: 15014204 [TBL] [Abstract][Full Text] [Related]
7. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Ramos M; Goñi-Allo B; Aguirre N Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107 [TBL] [Abstract][Full Text] [Related]
8. Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. Di Ciano P; Cardinal RN; Cowell RA; Little SJ; Everitt BJ J Neurosci; 2001 Dec; 21(23):9471-7. PubMed ID: 11717381 [TBL] [Abstract][Full Text] [Related]
9. Opposing roles of D1 and D2 receptors in appetitive conditioning. Eyny YS; Horvitz JC J Neurosci; 2003 Mar; 23(5):1584-7. PubMed ID: 12629161 [TBL] [Abstract][Full Text] [Related]
10. Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. Liu X; Weiss F J Pharmacol Exp Ther; 2002 Mar; 300(3):882-9. PubMed ID: 11861794 [TBL] [Abstract][Full Text] [Related]
11. Riluzole, a glutamate release inhibitor, and motor behavior. Kretschmer BD; Kratzer U; Schmidt WJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):181-90. PubMed ID: 9750003 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects on brain stimulation reward of D1 blockade or D2 stimulation combined with AMPA blockade in the extended amygdala and nucleus accumbens. Waraczynski M; Kuehn L; Schmid E; Stoehr M; Zwifelhofer W Behav Brain Res; 2015 Feb; 278():337-41. PubMed ID: 25453743 [TBL] [Abstract][Full Text] [Related]
13. AMPA/kainate, NMDA, and dopamine D1 receptor function in the nucleus accumbens core: a context-limited role in the encoding and consolidation of instrumental memory. Hernandez PJ; Andrzejewski ME; Sadeghian K; Panksepp JB; Kelley AE Learn Mem; 2005; 12(3):285-95. PubMed ID: 15930507 [TBL] [Abstract][Full Text] [Related]
14. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord. Chizh BA; Cumberbatch MJ; Headley PM Br J Pharmacol; 1994 Jul; 112(3):843-6. PubMed ID: 7522860 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors. Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188 [TBL] [Abstract][Full Text] [Related]
16. Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats. Nakamura K; Kurasawa M; Shirane M Brain Res; 2000 Apr; 862(1-2):266-9. PubMed ID: 10799697 [TBL] [Abstract][Full Text] [Related]
18. Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. Baldwin AE; Sadeghian K; Kelley AE J Neurosci; 2002 Feb; 22(3):1063-71. PubMed ID: 11826135 [TBL] [Abstract][Full Text] [Related]
19. Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466. Stephens DN; Brown G Alcohol Clin Exp Res; 1999 Dec; 23(12):1914-20. PubMed ID: 10630610 [TBL] [Abstract][Full Text] [Related]
20. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists. Maj J; Rogóz Z; Skuza G; Jaros T Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]